{ "model": { "rank": 14644, "code": "thing-q1364270", "model_id": "vr.tr.hypertrophic-cardiomyopathy", "name": "hypertrophic cardiomyopathy", "purpose": "Let an agent explain HCM in general terms, relay genetics, types, risks, treatment and family screening from cardiology sources, route collapse, fainting on exertion or chest pain to emergency care, describe the named forms and phenocopies, and distinguish HCM from athlete s heart, hypertensive heart disease, dilated cardiomyopathy and amyloidosis, without diagnosing individuals.", "family": "Thing Registry", "category": "Cross-cutting context", "status": "research-draft", "kind": "thing", "plane": "XCT", "domain": "XCT.STA", "industry": "", "version": "", "url": "/models/thing/q1364270/", "tier": 2, "score": 35, "payload": { "layer": "wikidata", "aliases": [ "cardiomyopathy, infantile hypertrophic", "mitochondrial disease with hypertrophic cardiomyopathy", "apical hypertrophic cardiomyopathy", "hypertrophic obstructive cardiomyopathy", "glycogen storage disease with hypertrophic cardiomyopathy", "lysosomal disease with hypertrophic cardiomyopathy", "fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy", "syndrome associated with hypertrophic cardiomyopathy", "non-familial hypertrophic cardiomyopathy", "familial hypertrophic cardiomyopathy" ], "aliasCount": 10, "merged": 10, "knownIn": 35, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q1364270", "url": "https://www.wikidata.org/wiki/Q1364270", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-13T21:50:35Z", "providers": [ "Claude" ], "breadth": "written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify", "pass": 2, "wave": 4, "engine": "claude" }, "metaModel": { "id": "THING-Q1364270", "registryId": "vr.tr.hypertrophic-cardiomyopathy", "name": "hypertrophic cardiomyopathy", "version": "0.2.0-wave.4", "entryKind": "thing", "family": "Thing Registry", "domain": [ "XCT.STA" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q1364270/", "model": { "registry_id": "vr.tr.hypertrophic-cardiomyopathy", "name": "hypertrophic cardiomyopathy", "purpose": "Let an agent explain HCM in general terms, relay genetics, types, risks, treatment and family screening from cardiology sources, route collapse, fainting on exertion or chest pain to emergency care, describe the named forms and phenocopies, and distinguish HCM from athlete s heart, hypertensive heart disease, dilated cardiomyopathy and amyloidosis, without diagnosing individuals.", "definition": "A condition in which the heart muscle, usually of the left ventricle, becomes abnormally thick without another cause such as high blood pressure, most often due to inherited sarcomere gene variants such as in MYH7 and MYBPC3, affecting roughly 1 in 500 people, with forms including hypertrophic obstructive cardiomyopathy, apical hypertrophic cardiomyopathy and infantile forms, and conditions that mimic it, such as glycogen storage, lysosomal storage and mitochondrial diseases with hypertrophic cardiomyopathy; it can cause breathlessness, chest pain, arrhythmias and sudden cardiac death, is managed with medicines including the cardiac myosin inhibitor mavacamten, approved in the United States in 2022, septal reduction and implantable defibrillators, and relatives are offered screening. Collapse needs CPR and a defibrillator immediately.", "what_it_is_for": "Not applicable; a heart muscle disease.", "affordances": [ "explain in general terms", "relay genetics and family screening", "describe named forms", "route cardiac emergencies" ], "distinguishing_features": [ "Inherited", "Thickened ventricle", "Sudden death risk", "Family screening" ], "appearance": "Not visible externally; seen on echocardiography or MRI as thickened heart walls.", "visual_identification": [ "Genetic thickening of the heart muscle", "Infantile hypertrophic cardiomyopathy, mitochondrial, glycogen storage and lysosomal disease with HCM, apical HCM, hypertrophic obstructive cardiomyopathy", "Athlete s heart is adaptive; hypertensive heart disease has a pressure cause; dilated cardiomyopathy thins walls; amyloidosis infiltrates tissue" ], "physical_properties": [ { "quantity": "prevalence", "typical_range": "about 1 in 500", "unit": "people", "note": "commonly cited" }, { "quantity": "common genes", "typical_range": "MYH7 and MYBPC3", "unit": "list", "note": "" }, { "quantity": "mavacamten FDA approval", "typical_range": "2022", "unit": "year", "note": "" }, { "quantity": "wall thickness criterion", "typical_range": "15 mm or more in adults", "unit": "note", "note": "typical diagnostic threshold" } ], "families_and_kinds": [ "obstructive HCM", "non-obstructive HCM", "apical HCM", "infantile HCM", "phenocopies such as storage and mitochondrial diseases" ], "related_models": [ { "relation": "is a kind of", "target": "intrinsic cardiomyopathy", "why": "in registry terms" }, { "relation": "is treated with", "target": "implantable cardioverter-defibrillator", "why": "for high risk" }, { "relation": "includes", "target": "hypertrophic obstructive cardiomyopathy", "why": "" }, { "relation": "is contrasted with", "target": "athletic heart syndrome", "why": "" } ], "identifiers": [], "standards_and_regulation": [ "ESC 2023 cardiomyopathy guidelines", "AHA/ACC 2024 HCM guideline", "Sports cardiology screening policies" ], "failure_modes_and_hazards": [ "Missing warning signs of sudden cardiac death", "Diagnosing individuals remotely", "Overstating sports restrictions without current guidance" ], "in_scope": [], "out_of_scope": [], "characteristics": [] }, "sources": [], "structure": { "bundles": [ { "id": "understand", "name": "Understand", "description": "What HCM is.", "rationale": "Attribution.", "layers": [ { "id": "definition", "name": "Definition", "description": "Definition.", "findings": [ { "id": "definition-finding", "name": "Definition", "description": "Definition.", "questions": [ { "text": "What is hypertrophic cardiomyopathy, and how does it differ from athlete s heart, hypertensive heart disease, dilated cardiomyopathy and amyloidosis?", "kind": "definition" }, { "text": "Has someone collapsed, fainted during exercise or has chest pain, in which case call emergency services, start CPR and use a defibrillator?", "kind": "boundary" } ] } ] }, { "id": "forms", "name": "Forms", "description": "Named forms.", "findings": [ { "id": "forms-finding", "name": "Forms", "description": "Forms.", "questions": [ { "text": "What are obstructive, apical and infantile HCM and storage and mitochondrial diseases with HCM?", "kind": "definition" }, { "text": "Which entry fits the specific form?", "kind": "action" } ] } ] } ] }, { "id": "medical", "name": "Medical", "description": "Genetics and diagnosis.", "rationale": "Attribution.", "layers": [ { "id": "genetics", "name": "Genetics", "description": "Genetics.", "findings": [ { "id": "genetics-finding", "name": "Genetics", "description": "Genetics.", "questions": [ { "text": "How is HCM inherited, and how are relatives screened?", "kind": "provenance" }, { "text": "Which references are standard?", "kind": "provenance" } ] } ] }, { "id": "diagnosis", "name": "Diagnosis", "description": "Diagnosis.", "findings": [ { "id": "diagnosis-finding", "name": "Diagnosis", "description": "Diagnosis.", "questions": [ { "text": "How is HCM diagnosed with ECG, echocardiography and MRI?", "kind": "provenance" }, { "text": "Which sources are cited?", "kind": "provenance" } ] } ] } ] }, { "id": "treatment", "name": "Treatment", "description": "Treatment.", "rationale": "Regulation.", "layers": [ { "id": "therapy", "name": "Therapy", "description": "Medicines and procedures.", "findings": [ { "id": "therapy-finding", "name": "Therapy", "description": "Therapy.", "questions": [ { "text": "How are beta blockers, myosin inhibitors and septal reduction used, in general terms?", "kind": "provenance" }, { "text": "Which entry fits mavacamten?", "kind": "action" } ] } ] }, { "id": "scd", "name": "Sudden death", "description": "Sudden death prevention.", "findings": [ { "id": "scd-finding", "name": "Sudden death", "description": "Sudden death.", "questions": [ { "text": "How do guidelines assess sudden death risk and ICD use?", "kind": "provenance" }, { "text": "Which entry fits sudden cardiac death?", "kind": "action" } ] } ] } ] }, { "id": "context", "name": "Context", "description": "Sport and support.", "rationale": "Context.", "layers": [ { "id": "sport", "name": "Sport", "description": "Sport participation.", "findings": [ { "id": "sport-finding", "name": "Sport", "description": "Sport.", "questions": [ { "text": "How have sports guidelines for people with HCM changed, with positions attributed?", "kind": "provenance" }, { "text": "Is the presentation current and attributed?", "kind": "boundary" } ] } ] }, { "id": "support", "name": "Support", "description": "Support.", "findings": [ { "id": "support-finding", "name": "Support", "description": "Support.", "questions": [ { "text": "Which organisations support families affected by cardiomyopathy?", "kind": "provenance" }, { "text": "Which entry fits Cardiomyopathy UK?", "kind": "action" } ] } ] } ] } ] }, "openQuestions": [ "Should phenocopies be separate entries?", "How should cardiology guidelines be linked?", "How should new therapies be kept current?" ], "statistics": { "bundles": 4, "layers": 8, "findings": 8, "questions": 16 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "abstract concept", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a hypertrophic cardiomyopathy, record what state it is in, and decide what may be done with it.", "whatItIs": "Let an agent explain HCM in general terms, relay genetics, types, risks, treatment and family screening from cardiology sources, route collapse, fainting on exertion or chest pain to emergency care, describe the named forms and phenocopies, and distinguish HCM from athlete s heart, hypertensive heart disease, dilated cardiomyopathy and amyloidosis, without diagnosing individuals.", "characteristics": { "substance": "abstract", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: cardiomyopathy, infantile hypertrophic, mitochondrial disease with hypertrophic cardiomyopathy, apical hypertrophic cardiomyopathy, hypertrophic obstructive cardiomyopathy, glycogen storage disease with hypertrophic cardiomyopathy, lysosomal disease with hypertrophic cardiomyopathy, fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy, syndrome associated with hypertrophic cardiomyopathy, non-familial hypertrophic cardiomyopathy, familial hypertrophic cardiomyopathy.", "10 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 35 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a hypertrophic cardiomyopathy, and on what evidence are they told apart?" ], "whatItIsMadeOf": "an abstraction with no physical instance", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "cardiomyopathy, infantile hypertrophic", "mitochondrial disease with hypertrophic cardiomyopathy", "apical hypertrophic cardiomyopathy", "hypertrophic obstructive cardiomyopathy", "glycogen storage disease with hypertrophic cardiomyopathy", "lysosomal disease with hypertrophic cardiomyopathy", "fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy", "syndrome associated with hypertrophic cardiomyopathy", "non-familial hypertrophic cardiomyopathy", "familial hypertrophic cardiomyopathy" ] } ], "standing": "Described in 35 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 10 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one hypertrophic cardiomyopathy from another, and a hypertrophic cardiomyopathy from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a hypertrophic cardiomyopathy sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a hypertrophic cardiomyopathy from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a hypertrophic cardiomyopathy passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a hypertrophic cardiomyopathy between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a hypertrophic cardiomyopathy, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a hypertrophic cardiomyopathy is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "definitions-in-contest", "name": "Definitions and who holds them", "description": "What hypertrophic cardiomyopathy is taken to mean, and by whom.", "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.", "layers": [ { "id": "competing-definitions", "name": "Competing definitions", "description": "The main readings and the traditions behind them.", "findings": [ { "id": "definition-map", "name": "Definitions and their holders", "description": "Each definition with the school or body that holds it.", "questions": [ { "id": "definition-map-q01", "text": "Which definitions of hypertrophic cardiomyopathy are in use, and which tradition or body holds each?", "kind": "definition" }, { "id": "definition-map-q02", "text": "What turns on the difference between them in practice?", "kind": "boundary" } ] } ] }, { "id": "operationalisation", "name": "Operationalisation", "description": "How it is measured or applied when it has to be.", "findings": [ { "id": "operational-record", "name": "Measures and proxies", "description": "Instruments and indicators used to stand in for it.", "questions": [ { "id": "operational-record-q01", "text": "How is hypertrophic cardiomyopathy operationalised or measured in practice, and by what instrument?", "kind": "measurement" }, { "id": "operational-record-q02", "text": "What does that operationalisation leave out, and when does that matter?", "kind": "boundary" } ] } ] } ] }, { "id": "instances-and-use", "name": "Instances, use and consequence", "description": "What counts as an instance of hypertrophic cardiomyopathy and what follows from calling something that.", "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.", "layers": [ { "id": "instances", "name": "What counts as an instance", "description": "Clear cases, borderline cases and non-cases.", "findings": [ { "id": "instance-tests", "name": "Tests for an instance", "description": "What would settle whether something falls under it.", "questions": [ { "id": "instance-tests-q01", "text": "What would settle whether something is an instance of hypertrophic cardiomyopathy?", "kind": "boundary" }, { "id": "instance-tests-q02", "text": "Which borderline cases are argued about, and on what grounds?", "kind": "definition" } ] } ] }, { "id": "consequence", "name": "Consequence of application", "description": "Rights, duties or decisions that follow from the label.", "findings": [ { "id": "consequence-record", "name": "What the label licenses", "description": "What an agent may do once something is classified this way.", "questions": [ { "id": "consequence-record-q01", "text": "What follows practically once something is treated as hypertrophic cardiomyopathy?", "kind": "action" }, { "id": "consequence-record-q02", "text": "What must an agent not infer from the label alone?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a hypertrophic cardiomyopathy came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a hypertrophic cardiomyopathy and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a hypertrophic cardiomyopathy is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a hypertrophic cardiomyopathy, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a hypertrophic cardiomyopathy, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a hypertrophic cardiomyopathy is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 5, "layers": 10, "findings": 12, "questions": 32 } } } }